[Other] Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial

STOTTT Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-23 00:24
Reward20points

Edited by STOTTT at 2026-6-20 00:24

journal:EuroIntervention

Authors:Frans B. Mensink; Jonathan Los; Mohamed M. Reda Morsy; Rohit M. Oemrawsingh; Clemens von Birgelen; Alexander J.J. Ijsselmuiden; Martijn Meuwissen; Jin M. Cheng; Diederik F. van Wijk; Pieter C. Smits; Valeria Paradies; Dirk J. van Wijk; Himanshu Rai; Tim J.F. ten Cate; Cyril Camaro; Peter Damman; Lokien X. van Nunen; Aukelien C. Dimitriu-Leen; Marleen H. van Wely; Aysun Cetinyurek-Yavuz; Robert A. Byrne; Niels van Royen; Robert-Jan M. van Geuns

Published date:2025-8-

DOI:10.4244/eij-d-24-01065

Article link:https://doi.org/10.4244/eij-d-24-01065

Article Source:Europa Digital & Publishing


Remark:125
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list